Cathy L McCarthy
CIK 1170433 · Pres/CEO · last filed 2026-08-31
Cathy L McCarthy is a Pres/CEO who has filed 54 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for MFP, was dated Aug 31, 2026. Across all open-market trades the lifetime net is −$3.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.9M across reported positions. 19 SEC filings were submitted jointly with MIDDLEBY Corp.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RGTIW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ELGIN, IL 60120
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MFP | Director | 11,589 | $45.86 | $531.5K | $0 | 2 | 2026-08-31 |
| MIDD | Director | 10,880 | $140.07 | $1.52M | -$431.1K | 16 | 2026-03-06 |
| RGTIW | Director | 234,234 | $3.45 | $808.1K | -$1.73M | 6 | 2025-03-12 |
| SOLTA MEDICAL INC (SLTM) Delisted | Director | 109,602 | — | — | $21.3K | 7 | 2013-06-07 |
| SM&A (WINS) Delisted | President & CEO | 34,714 | — | — | -$845.7K | 9 | 2008-06-06 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-31 | MFP | Grant (A) | +5,672 | $0 | EDGAR |
| 2026-08-03 | MFP | Grant (A) | +10,734 | $0 | EDGAR |
| 2026-03-06 | MIDD | Grant (A) | +1,161 | $0 | EDGAR |
| 2025-07-21 | RGTI | Notice (144) | −50,000 | -$804.0K | EDGAR |
| 2025-07-11 | RGTI | Notice (144) | −50,000 | -$609.0K | EDGAR |
| 2025-06-30 | RGTI | Notice (144) | −25,000 | -$300.0K | EDGAR |
| 2025-06-23 | RGTI | Notice (144) | −50,000 | -$523.0K | EDGAR |
| 2025-06-20 | RGTI | Notice (144) | −50,000 | -$553.0K | EDGAR |
| 2025-03-12 | RGTIW | Sell (S) | −150,000 | -$1.20M | EDGAR |
| 2025-03-11 | RGTI | Notice (144) | −150,000 | -$1.19M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.